IL6 and breast carcinoma: Our findings demonstrate a significant upregulation of key pro-inflammatory cytokines such as IL-6, IL-1β, TNF-α, and IL-12 (p40) in the plasma of breast cancer patients, with expression correlating positively with tumor stage and grade.